Literature DB >> 24691972

Up-regulation of microRNA-138 induce radiosensitization in lung cancer cells.

Hui Yang1, Yue Tang, Wei Guo, Yuwen Du, Yuanyuan Wang, Ping Li, Wenqiao Zang, Xiaojun Yin, Huaqi Wang, Heying Chu, Guojun Zhang, Guoqiang Zhao.   

Abstract

Deregulation of microRNAs (miRNAs) is implicated in tumor progression. We attempt to identify the association between miR-138 and Sentrin/SUMO-specific protease 1 (SENP1) as a radiosensitization-related gene and characterize the biological function by which SENP1 was regulated by miR-138 to influence radiosensitization in lung cancer cells. In this study, we showed that miRNA-138 is reduced in both lung cancer clinical specimens and cell lines and is effective to inhibit SENP1 expression. Moreover, high levels of miR-138 are associated with lower levels of lung cancer cell proliferation and colony formation. Then, we investigated the underlying mechanisms responsible for the increase in the radiosensitivity of lung cancer cells when SENP1 is inhibited by miR-138. We further show that the increased radiosensitivity may be the result of an increased γ-H2AX expression, an increased rate of apoptosis, and changes in the cell cycle. In conclusion, our data demonstrate that the miR-138/SENP1 cascade is relative to radiosensitization in lung cancer cells and is a potential radiotherapy target.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24691972     DOI: 10.1007/s13277-014-1879-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Advances in three-dimensional conformal radiation therapy physics with intensity modulation.

Authors:  S Webb
Journal:  Lancet Oncol       Date:  2000-09       Impact factor: 41.316

2.  MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.

Authors:  Ji-Guang Zhang; Jian-Feng Guo; Dong-Lei Liu; Quan Liu; Jian-Jun Wang
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

3.  The controlling role of ATM in homologous recombinational repair of DNA damage.

Authors:  C Morrison; E Sonoda; N Takao; A Shinohara; K Yamamoto; S Takeda
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 4.  Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.

Authors:  Mark W Dewhirst; Yiting Cao; Chuan Yuan Li; Benjamin Moeller
Journal:  Radiother Oncol       Date:  2007-06-08       Impact factor: 6.280

Review 5.  [Intrinsic radiosensitivity and DNA double-strand breaks in human cells].

Authors:  A Joubert; N Foray
Journal:  Cancer Radiother       Date:  2007-02-23       Impact factor: 1.018

6.  Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.

Authors:  Neelam Taneja; Mandel Davis; John S Choy; Michael A Beckett; Rachana Singh; Stephen J Kron; Ralph R Weichselbaum
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

7.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

8.  Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.

Authors:  Limin Long; Guoqing Huang; Hongyi Zhu; Yonghong Guo; Youshuo Liu; Jirong Huo
Journal:  J Transl Med       Date:  2013-10-30       Impact factor: 5.531

9.  MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

Authors:  Yukari Takahashi; Alistair R R Forrest; Emi Maeno; Takehiro Hashimoto; Carsten O Daub; Jun Yasuda
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

10.  Advances in lung cancer surgery.

Authors:  Mark W Hennon; Sai Yendamuri
Journal:  J Carcinog       Date:  2012-12-31
View more
  23 in total

1.  MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

Authors:  Jun Wei; Edjah K Nduom; Ling-Yuan Kong; Yuuri Hashimoto; Shuo Xu; Konrad Gabrusiewicz; Xiaoyang Ling; Neal Huang; Wei Qiao; Shouhao Zhou; Cristina Ivan; Greg N Fuller; Mark R Gilbert; Willem Overwijk; George A Calin; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2015-12-11       Impact factor: 12.300

2.  Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

Authors:  Lihong Han; Guoxiu Zhang; Nali Zhang; Haiyan Li; Yanyan Liu; Aiguo Fu; Youguang Zheng
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.

Authors:  Yuanyuan Wang; Xiaonan Chen; Xuanyu Hu; Ren Zhang; Yuwen Du; Wenqiao Zang; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-10

Review 4.  Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.

Authors:  Zhen-Jun Zhao; Jun Shen
Journal:  RNA Biol       Date:  2015-12-09       Impact factor: 4.652

5.  Anticancer function of α-solanine in lung adenocarcinoma cells by inducing microRNA-138 expression.

Authors:  Furui Zhang; Rui Yang; Guojun Zhang; Ruirui Cheng; Yong Bai; Huasi Zhao; Xinhua Lu; Hui Li; Shanshan Chen; Juan Li; Shujun Wu; Ping Li; Xiaonan Chen; Qianqian Sun; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2015-12-02

6.  MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α.

Authors:  Yao Chen; K E Cao; Shaohua Wang; Jia Chen; Bin He; G U He; Yong Chen; Bin Peng; Jianda Zhou
Journal:  Exp Ther Med       Date:  2016-04-04       Impact factor: 2.447

7.  miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3.

Authors:  Youngmi Kim; Hyuna Kim; Deokbum Park; Dooil Jeoung
Journal:  Mol Cells       Date:  2015-05-22       Impact factor: 5.034

8.  miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma.

Authors:  Fotini M Kouri; Lisa A Hurley; Weston L Daniel; Emily S Day; Youjia Hua; Liangliang Hao; Chian-Yu Peng; Timothy J Merkel; Markus A Queisser; Carissa Ritner; Hailei Zhang; C David James; Jacob I Sznajder; Lynda Chin; David A Giljohann; John A Kessler; Marcus E Peter; Chad A Mirkin; Alexander H Stegh
Journal:  Genes Dev       Date:  2015-04-01       Impact factor: 11.361

9.  SENP1 modulates microglia-mediated neuroinflammation toward intermittent hypoxia-induced cognitive decline through the de-SUMOylation of NEMO.

Authors:  Hongwei Wang; Tianyun Yang; Jinyuan Sun; Sisen Zhang; Song Liu
Journal:  J Cell Mol Med       Date:  2021-06-13       Impact factor: 5.310

10.  Depletion of SENP1-mediated PPARγ SUMOylation exaggerates intermittent hypoxia-induced cognitive decline by aggravating microglia-mediated neuroinflammation.

Authors:  Hongwei Wang; Wei Xiong; Sitong Hang; Yanmin Wang; Sisen Zhang; Song Liu
Journal:  Aging (Albany NY)       Date:  2021-05-25       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.